Free 15% Customization On All Syndicated Reports.

Global Transplant Diagnostics Devices Market – Industry analysis and forecast (2017 to 2024) – By Technology, Product and Service, Transplant, Application and Region.

Market Scenario

Global Transplant Diagnostics Devices Market was valued at USD3.25 billion in 2017, and is estimated to grow at a CAGR of 7.5% from 2017 to 2024. Global Transplant Diagnostics Devices Market Transplant diagnostics is the most important histocompatibility in humans, which is quite consistent with chromosome six-based genes. Human leukocyte antigen (HLA) diagnostic testing is done to determine tissue consistency between the oxy and bone marrow transplant contributor and recipients. A few key factors boosting the overall growth of transplant diagnostics include increase in number of transplantation procedures and the rise in number of patients suffering from chronic diseases frequently leading to organ failure. In addition to this, it is the industrial advancements in the field of transplant diagnostics, growth in finance for the research activities, and rise in impediment of infectious diseases are some other important factors responsible for the upsurge in the Global Transplant Diagnostics Devices Market. Global Transplant Diagnostics Devices Market is segmented by technology, product and services, transplant type, application, end user, and region. The global transplant diagnostics devices have the largest usage in independent reference laboratories, hospitals, transplant centre, and research laboratories & academic institutes. As the different regions are taken into consideration, North America among all others held the highest Global Transplant Diagnostics Devices Market share in 2016 followed by Europe, and is estimated to grow at the highest growth rate during the forecast period. The auxiliary regime initiatives and considerable enforcement of practice guidelines relinquished by healthcare organizations present across this region are some of the key factors responsible for the high share registered by the North America region. Furthermore, high adoption of amended medicines, stem cell therapies, and soft tissue transplants are also enhancing the regional market magnification of the Global Transplant Diagnostics Devices Market. The major players in the Global Transplant Diagnostics Devices Market are Abbott Laboratories Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Illumina, Inc., Immucor, Inc., Linkage Biosciences, Olerup Ssp Ab, Qiagen N.V., bioMérieux, Becton, Dickinson and Company, Merck KGAA, Hologic, Luminex, Thermo Fisher Scientific Inc., and Sigma-Aldrich among others. The years that have been considered for the study are: • Base year – 2016 • Estimated year – 2017 • Forecast period – 2017 to 2024 Market Scope: By Technology: • Molecular Assay Technologies • PCR-Based Molecular Assay Technologies o Real-Time PCR o Sequence-Specific Primer-PCR (SSP-PCR) o Sequence-Specific Oligonucleotide-PCR (SSO-PCR) o Other PCR Technologies • Sequencing-Based Molecular Assay Technologies o Sanger Sequencing o Next-Generation Sequencing (NGS) o Other Sequencing Technologies • Non-Molecular Assay Technologies By Products & Service: • Reagents & Consumables • Instruments • Software & Services By Transplant Type: • Solid Organ Transplantation o Kidney o Liver o Lung o Heart o Pancreas o Other Organs • Stem Cell Transplantation • Soft Tissue Transplantation By Application: • Diagnostic Application • Pre-Transplantation o Infectious Diseases Testing o Histocompatibility Testing o Blood Profiling • Post-Transplantation • Research Application By End Users: • Independent Reference Laboratories • Hospitals & Transplant Centres • Research Laboratories & Academic Institutes By Region: North America • U.S • Canada Europe • Germany • France • UK • Italy • Spain • Russia • Rest of Europe Asia Pacific • Japan • China • India • South Korea • Australia • Rest of Asia Pacific Rest of the World (ROW): • Middle-East • Africa • Latin America Research Methodology: The market is estimated by analysing the data points obtained from various sources and conducting them into a predictor model created specifically for each individual market. The data points are extracted from paid and unpaid sources along with paid primary interviews with key opinion leaders in the market. Key opinion leaders from both demand and supply sides of market were considered while conducting interviews to get unbiased idea of the market. This exercise was done at country level to get fair idea of the market in countries considered for this analysis. This country specific analysis was accumulated to establish regional numbers and then arrive at global market value for global transplant diagnostics Market. Global Medical Non-Woven Disposable Market - Forecast 2024

Table of Contents

1. INTRODUCTION 1.1. Market description & Scope (2016-2024) 1.2. Objectives 1.2.1. Key Takeaways 1.2.2. Abbreviations & Acronyms 2. RESEARCH METHODOLOGY 2.1. Methods used for market forecasting 2.2. Data Sources 2.2.1. Paid Databases 2.2.2. Primary Sources 2.2.3. Secondary Sources 3. EXECUTIVE SUMMARY 3.1. Major Findings 3.1.1. Key Segment Trends 3.1.1.1. Technology 3.1.1.2. Products & Service 3.1.1.3. Transplant Type 3.1.1.4. Application 3.1.1.5. End-User 3.1.2. Key Regional Trends 3.1.2.1. North America 3.1.2.2. Europe 3.1.2.3. Asia Pacific 3.1.2.4. Middle-East 3.1.2.5. Latin America 3.2. Key Companies and their Strategies 4. MARKET OVERVIEW 4.1. Transplant Diagnostics Concept & Definition 4.2. Segments Overview 4.2.1. By Technology 4.2.1.1. Molecular Assay Technologies 4.2.1.2. PCR-Based Molecular Assay Technologies 4.2.1.2.1. Real-Time PCR 4.2.1.2.2. Sequence-Specific Primer-PCR (SSP-PCR) 4.2.1.2.3. Sequence-Specific Oligonucleotide-PCR (SSO-PCR) 4.2.1.2.4. Other PCR Technologies 4.2.1.3. Sequencing-Based Molecular Assay Technologies 4.2.1.3.1. Sanger Sequencing 4.2.1.3.2. Next-Generation Sequencing (NGS) 4.2.1.3.3. Other Sequencing Technologies 4.2.1.4. Non-Molecular Assay Technologies 4.2.2. By Products & Service 4.2.2.1. Reagents & Consumables 4.2.2.2. Instruments 4.2.2.3. Software & Services 4.2.3. By Transplant Type 4.2.3.1. Solid Organ Transplantation 4.2.3.1.1. Kidney 4.2.3.1.2. Liver 4.2.3.1.3. Lung 4.2.3.1.4. Heart 4.2.3.1.5. Pancreas 4.2.3.1.6. Other Organs 4.2.3.2. Stem Cell Transplantation 4.2.3.3. Soft Tissue Transplantation 4.2.4. By Application 4.2.4.1. Diagnostic Application 4.2.4.2. Pre-Transplantation 4.2.4.2.1. Infectious Diseases Testing 4.2.4.2.2. Histocompatibility Testing 4.2.4.2.3. Blood Profiling 4.2.4.3. Post-Transplantation 4.2.4.4. Research Application 4.2.5. By End-User 4.2.5.1. Independent Reference Laboratories 4.2.5.2. Hospitals & Transplant Centers 4.2.5.3. Research Laboratories & Academic Institutes 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Porter’s Analysis 4.5. PESTLE Analysis 4.6. Fragmentation 4.6.1. Key strategic Alliances of companies (inorganic & organic) 4.6.2. Company Market Share (Top 10 Players) 4.6.3. Comparative Analysis of Key players in Transplant Diagnostics 4.7. Key Trends 5. GLOBAL TRANSPLANT DIAGNOSTICS TECHNOLOGY ESTIMATES & TREND ANALYSIS (2016 – 2024) 5.1. Global Transplant Diagnostics Market: Technology Analysis 5.1.1. Molecular Assay Technologies 5.1.1.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 5.1.2. PCR-Based Molecular Assay Technologies 5.1.2.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 5.1.3. Sequencing-Based Molecular Assay Technologies 5.1.3.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 5.1.4. Non-Molecular Assay Technologies 5.1.4.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 5.2. Global Transplant Diagnostics Market: Technology Trends 6. GLOBAL TRANSPLANT DIAGNOSTICS PRODUCTS & SERVICE ESTIMATES & TREND ANALYSIS (2016 – 2024) 6.1. Global Transplant Diagnostics Market: Products & Service Analysis 6.1.1. Reagents & Consumables 6.1.1.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 6.1.2. Instruments 6.1.2.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 6.1.3. Software & Services 6.1.3.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 6.2. Global Transplant Diagnostics Market: Products & Service Trends 7. GLOBAL TRANSPLANT DIAGNOSTICS TRANSPLANT TYPE ESTIMATES & TREND ANALYSIS (2016 – 2024) 7.1. Global Transplant Diagnostics Market: Transplant Type Analysis 7.1.1. Solid Organ Transplantation 7.1.1.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 7.1.2. Stem Cell Transplantation 7.1.2.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 7.1.3. Soft Tissue Transplantation 7.1.3.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 7.2. Global Transplant Diagnostics Market: Transplant Type Trends 8. GLOBAL TRANSPLANT DIAGNOSTICS APPLICATION ESTIMATES & TREND ANALYSIS (2016 – 2024) 8.1. Global Transplant Diagnostics Market: Application Analysis 8.1.1. Diagnostic Application 8.1.1.1. Market Share and growth forecasts,2016 – 2024 (USD Billion) 8.1.2. Pre-Transplantation 8.1.2.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 8.1.3. Post-Transplantation 8.1.3.1. Market Share and growth forecasts,2016 – 2024 (USD Billion) 8.1.4. Research Application 8.1.4.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 8.2. Global Transplant Diagnostics Market: Application Trends 9. GLOBAL TRANSPLANT DIAGNOSTICS END-USER ESTIMATES & TREND ANALYSIS (2016 – 2024) 9.1. Global Transplant Diagnostics Market: End-User Analysis 9.1.1. Independent Reference Laboratories 9.1.1.1. Market Share and growth forecasts,2016 – 2024 (USD Billion) 9.1.2. Hospitals & Transplant Centres 9.1.2.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 9.1.3. Research Laboratories & Academic Institutes 9.1.3.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 9.2. Global Transplant Diagnostics Market: End-User Trends 10. REGIONAL ESTIMATES & TREND ANALYSIS (2016 – 2024) 10.1. Global Transplant Diagnostics market share by Region, 2016 & 2025 10.2. North America 10.2.1. North America Transplant Diagnostics market, Market Share and growth forecasts, 2016 – 2024 (USD Billion) 10.2.2. Transplant Diagnostics Drivers For North America Market 10.2.3. Market Share Analysis and Growth Forecast, by Country 10.2.3.1. US 10.2.3.2. Canada 10.2.4. Country-wise GDP Growth Forecast 10.2.5. Transplant Diagnostics Trends In North America Market 10.3. Europe 10.3.1. Europe Transplant Diagnostics market, Market Share and growth forecasts, 2016 – 2024 (USD Billion) 10.3.2. Transplant Diagnostics Drivers For Europe Market 10.3.3. Market Share Analysis and Growth Forecast, by Country 10.3.3.1. UK 10.3.3.2. Germany 10.3.3.3. France 10.3.3.4. Russia 10.3.3.5. Spain 10.3.3.6. Italy 10.3.3.7. Others 10.3.4. Country-wise GDP Growth Forecast 10.3.5. Transplant Diagnostics Trends In Europe Market 10.4. Asia Pacific 10.4.1. Asia Pacific Transplant Diagnostics market, Market Share and growth forecasts, 2016 – 2024 (USD Billion) 10.4.2. Transplant Diagnostics Drivers For Asia Pacific Market 10.4.3. Market Share Analysis and Growth Forecast, by Country 10.4.3.1. China 10.4.3.2. Japan 10.4.3.3. India 10.4.3.4. South Korea 10.4.3.5. Australia 10.4.3.6. Others 10.4.4. Country-wise GDP Growth Forecast 10.4.5. Transplant Diagnostics Trends In Asia Pacific Market 10.5. Middle-east 10.5.1. Middle-east Transplant Diagnostics market, Market Share and growth forecasts, 2016 – 2024 (USD Billion) 10.5.2. Transplant Diagnostics Drivers For Middle-east Market 10.5.3. Market Share Analysis and Growth Forecast, by Country 10.5.3.1. GCC Countries 10.5.3.2. Saudi Arabia 10.5.4. Country-wise GDP Growth Forecast 10.5.5. Transplant Diagnostics Trends In Middle-east Market 10.6. Latin America 10.6.1. Latin America Transplant Diagnostics market, Market Share and growth forecasts, 2016 – 2024 (USD Billion) 10.6.2. Transplant Diagnostics Drivers For Latin America Market 10.6.3. Market Share Analysis and Growth Forecast, by Country 10.6.3.1. Brazil 10.6.3.2. Mexico 10.6.3.3. Others 10.6.4. Country-wise GDP Growth Forecast 10.6.5. Transplant Diagnostics Trends In Latin America Market 11. MARKET SHARE ANALYSIS 11.1. Key Players Regional Market share Analysis 11.1.1. North America 11.1.2. Europe 11.1.3. Asia Pacific 11.1.4. Middle-east 11.1.5. Latin America 12. MARKET COMPETITION ANALYSIS 12.1. Strategy Framework 12.2. Consolidation 12.2.1. Patent Analysis 12.2.2. Mergers & Acquisitions 12.2.2.1. Source Based 12.2.2.2. Services Based 12.2.2.3. Region Based 12.2.2.4. List of Mergers & Acquisitions 12.2.3. Company Benchmarking (Revenue & Profit Based) 12.2.4. Strategic Assessment of Company Consolidations 12.2.5. Emerging Business Models 12.3. Company Profiles 12.3.1. Abbott Laboratories Inc. 12.3.1.1. Company overview 12.3.1.2. Key financials 12.3.1.3. Geographical presence 12.3.1.4. Source and Business Segments 12.3.1.5. Strategic initiatives 12.3.1.6. SWOT analysis 12.3.1.7. Competitive positioning and landscape 12.3.2. Bio-Rad Laboratories Inc. 12.3.2.1. Company overview 12.3.2.2. Key financials 12.3.2.3. Geographical presence 12.3.2.4. Source and Business Segments 12.3.2.5. Strategic initiatives 12.3.2.6. SWOT analysis 12.3.2.7. Competitive positioning and landscape 12.3.3. F. Hoffmann-La Roche Ltd. 12.3.3.1. Company overview 12.3.3.2. Key financials 12.3.3.3. Geographical presence 12.3.3.4. Source and Business Segments 12.3.3.5. Strategic initiatives 12.3.3.6. SWOT analysis 12.3.3.7. Competitive positioning and landscape 12.3.4. Illumina, Inc. 12.3.4.1. Company overview 12.3.4.2. Key financials 12.3.4.3. Geographical presence 12.3.4.4. Source and Business Segments 12.3.4.5. Strategic initiatives 12.3.4.6. SWOT analysis 12.3.4.7. Competitive positioning and landscape 12.3.5. Immucor, Inc. 12.3.5.1. Company overview 12.3.5.2. Key financials 12.3.5.3. Geographical presence 12.3.5.4. Source and Business Segments 12.3.5.5. Strategic initiatives 12.3.5.6. SWOT analysis 12.3.5.7. Competitive positioning and landscape 12.3.6. Linkage Biosciences 12.3.6.1. Company overview 12.3.6.2. Key financials 12.3.6.3. Geographical presence 12.3.6.4. Source and Business Segments 12.3.6.5. Strategic initiatives 12.3.6.6. SWOT analysis 12.3.6.7. Competitive positioning and landscape 12.3.7. Olerup Ssp Ab 12.3.7.1. Company overview 12.3.7.2. Key financials 12.3.7.3. Geographical presence 12.3.7.4. Source and Business Segments 12.3.7.5. Strategic initiatives 12.3.7.6. SWOT analysis 12.3.7.7. Competitive positioning and landscape 12.3.8. Qiagen N.V. 12.3.8.1. Company overview 12.3.8.2. Key financials 12.3.8.3. Geographical presence 12.3.8.4. Source and Business Segments 12.3.8.5. Strategic initiatives 12.3.8.6. SWOT analysis 12.3.8.7. Competitive positioning and landscape 12.3.9. bioMérieux 12.3.9.1. Company overview 12.3.9.2. Key financials 12.3.9.3. Geographical presence 12.3.9.4. Source and Business Segments 12.3.9.5. Strategic initiatives 12.3.9.6. SWOT analysis 12.3.9.7. Competitive positioning and landscape 12.3.10. Becton, Dickinson and Company 12.3.10.1. Company overview 12.3.10.2. Key financials 12.3.10.3. Geographical presence 12.3.10.4. Source and Business Segments 12.3.10.5. Strategic initiatives 12.3.10.6. SWOT analysis 12.3.10.7. Competitive positioning and landscape 12.3.11. Merck KGAA 12.3.11.1. Company overview 12.3.11.2. Key financials 12.3.11.3. Geographical presence 12.3.11.4. Source and Business Segments 12.3.11.5. Strategic initiatives 12.3.11.6. SWOT analysis 12.3.11.7. Competitive positioning and landscape 12.3.12. Hologic 12.3.12.1. Company overview 12.3.12.2. Key financials 12.3.12.3. Geographical presence 12.3.12.4. Source and Business Segments 12.3.12.5. Strategic initiatives 12.3.12.6. SWOT analysis 12.3.12.7. Competitive positioning and landscape 12.3.13. Luminex 12.3.13.1. Company overview 12.3.13.2. Key financials 12.3.13.3. Geographical presence 12.3.13.4. Source and Business Segments 12.3.13.5. Strategic initiatives 12.3.13.6. SWOT analysis 12.3.13.7. Competitive positioning and landscape 12.3.14. Thermo Fisher Scientific Inc. 12.3.14.1. Company overview 12.3.14.2. Key financials 12.3.14.3. Geographical presence 12.3.14.4. Source and Business Segments 12.3.14.5. Strategic initiatives 12.3.14.6. SWOT analysis 12.3.14.7. Competitive positioning and landscape 12.3.15. Sigma-Aldrich 12.3.15.1. Company overview 12.3.15.2. Key financials 12.3.15.3. Geographical presence 12.3.15.4. Source and Business Segments 12.3.15.5. Strategic initiatives 12.3.15.6. SWOT analysis 12.3.15.7. Competitive positioning and landscape

Inquiry Before Buying

Request Sample

About This Report

Report ID10869
Category Healthcare
Publisher Name
No of Pages
Total Views
Published Date
Contact Us